Radiological Imaging in Thyroid Cancer

Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Please check if identified heading levels are correct.

References

  1. 1.
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. 2006;295(18):2164-2167.Google Scholar
  2. 2.
    Frates MC, Benson CB, Charbonneau JW. Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus statement. Radiology. 2005;237:794–800.CrossRefPubMedGoogle Scholar
  3. 3.
    Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87(5):1941–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Hambly NM, Gonen M, Gerst SR. Implementation of Evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards. Am J Roentgenol. 2011;196:655–60.CrossRefGoogle Scholar
  5. 5.
    King AD. Imaging for staging and management of thyroid cancer. Cancer Imaging. 2008;8(1):57–69.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR, British Thyroid Association. Management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1):1–122.  https://doi.org/10.1111/cen.12515. CrossRefPubMedGoogle Scholar
  7. 7.
    Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US features of thyroid malignancy: pearls and pitfalls. RSNA Educ Exhibits. 2007;27(3).Google Scholar
  8. 8.
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov;19(11):1167–214.CrossRefGoogle Scholar
  9. 9.
    Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Bonavita JA, Mayo J, Babb J, Bennett G, Oweity T, Macari M, Yee J. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol. 2009;193:207–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH, Thyroid Study Group, Korean Society of Neuro-and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study. Radiology. 2008;247:762–70.CrossRefPubMedGoogle Scholar
  12. 12.
    Chan BK, Desser TS, IR MD, Weigel RJ, Jeffrey RB Jr. Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med. 2003;22(10):1083–10913.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim BK, Choi YS, Kwon HJ, et al. Relationships between patterns of calcification in thyroid nodules and histopathologic findings. Endocr J. 2013;60:155–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Leenhardt L, Hejblum G, Franc B, Fediaevsky LD, Delbot T, Le Guillouzic D, Ménégaux F, Guillausseau C, Hoang C, Turpin G, Aurengo A. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab. 1999;84:24–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Ahn SS, Kim E-K, Kang DR. Biopsy of thyroid nodules: comparison of three sets of guidelines. Am J Roentgenol. 2010;194:31–7.CrossRefGoogle Scholar
  16. 16.
    Moon WJ, Kwag HJ, Na DG. Are there any specific ultrasound findings of nodular hyperplasia (“leave me alone” lesion) to differentiate it from follicular adenoma? Acta Radiol. 2009;50:383–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103:1330–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Jun P, Chow LC, Jeffrey RB. The sonographic features of papillary thyroid carcinomas: pictorial essay. Ultrasound Q. 2005;21(1):39–45.PubMedGoogle Scholar
  19. 19.
    Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol. 2002;178:687–91.CrossRefGoogle Scholar
  20. 20.
    Gharib H, Papini E, Duick D, et al. American association of clinical endocrinologist, associatione medici endocrinologi, and European thyroid association, medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006;12(1):63–102.Google Scholar
  21. 21.
    Frates MC, Benson CB, Charboneau JW, Cibas ES. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005;237(3):794–800.CrossRefPubMedGoogle Scholar
  22. 22.
    Choi SH, Han KH, Yoon JH, et al. Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. Clin Endocrinol (Oxf). 2011;74:776–782.23.CrossRefGoogle Scholar
  23. 23.
    Aron M, Mallik A, Verma K. Fine needle aspiration cytology of follicular variant of papillary carcinoma of the thyroid: morphologic pointers to its diagnosis. Acta Cytol. 2006;50:663–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Yousem DM, Hatabu H, Hurst RW, et al. Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology. 1995;195:715–20.CrossRefPubMedGoogle Scholar
  25. 25.
    Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg. 1998;133:276–80.CrossRefPubMedGoogle Scholar
  26. 26.
    Palazzo FF, Gosnell J, Savio R, et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol. 2006;32:340–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Ahuja AT, Chow L, Chik W, King W, Metreweli C. Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin Radiol. 1995;50:229–31.CrossRefPubMedGoogle Scholar
  28. 28.
    Rosario PW, de Faria S, Bicalho L, et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med. 2005;24:1385–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Sugenoya A, Asanuma K, Shingu K, et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery. 1993;113:541–5.PubMedGoogle Scholar
  30. 30.
    Küçük ON, Gültekin SS, Aras G, Ibiş E. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer. Nucl Med Commun. 2006;27(3):261–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Conry BG, Papathanasiou ND, Prakash V, et al. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2010;37(1):49–57.CrossRefPubMedGoogle Scholar
  32. 32.
    Castellani MR, Seregni E, Maccauro M. etal MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role? J. Nucl Med Mol Imaging. 2008;52(4):430–40.Google Scholar
  33. 33.
    Int Rosenbluth BD, Serrano V, Happersett L, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. J Radiat Oncol Biol Phys. 2005;63(5):1419–26.CrossRefGoogle Scholar
  34. 34.
    National Cancer Institute guidance. Thyroid cancerGoogle Scholar
  35. 35.
    Antonelli A, Miccoli P, Ferdeghini M, et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid. 1995;5(1):25–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G. Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma. Nucl Med Commun. 2011;32(12):1162–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM. PET/CT in the management of thyroid cancer. AJR Am J Roentgenol. 2014;202(6):1316–29.  https://doi.org/10.2214/AJR.13.11673.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Royal Liverpool and Broadgreen University Hospitals NHS TrustLondonUK

Personalised recommendations